These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2604461

  • 21. Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.
    El-On J, Jacobs GP, Witztum E, Greenblatt CL.
    Antimicrob Agents Chemother; 1984 Nov; 26(5):745-51. PubMed ID: 6517557
    [Abstract] [Full Text] [Related]

  • 22. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, Bettaieb J, Gharbi A, Belhadj Hamida N, Boukthir A, Chlif S, Abdelhamid K, El Ahmadi Z, Louzir H, Mokni M, Morizot G, Buffet P, Smith PL, Kopydlowski KM, Kreishman-Deitrick M, Smith KS, Nielsen CJ, Ullman DR, Norwood JA, Thorne GD, McCarthy WF, Adams RC, Rice RM, Tang D, Berman J, Ransom J, Magill AJ, Grogl M.
    N Engl J Med; 2013 Feb 07; 368(6):524-32. PubMed ID: 23388004
    [Abstract] [Full Text] [Related]

  • 23. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec 07; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 24. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
    Krause G, Kroeger A.
    Trans R Soc Trop Med Hyg; 1994 Dec 07; 88(1):92-4. PubMed ID: 8154018
    [Abstract] [Full Text] [Related]

  • 25. Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana.
    el-On J, Cawich F, Evans DA, Weinrauch L.
    Int J Parasitol; 1993 Feb 07; 23(1):121-7. PubMed ID: 8468127
    [Abstract] [Full Text] [Related]

  • 26. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
    Aguiar MG, Pereira AM, Fernandes AP, Ferreira LA.
    Antimicrob Agents Chemother; 2010 Nov 07; 54(11):4699-704. PubMed ID: 20713665
    [Abstract] [Full Text] [Related]

  • 27. Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.
    Kim DH, Chung HJ, Bleys J, Ghohestani RF.
    PLoS Negl Trop Dis; 2009 Nov 07; 3(2):e381. PubMed ID: 19221595
    [Abstract] [Full Text] [Related]

  • 28. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV, Fernandes AP, Ferreira LA.
    Parasitol Res; 2007 May 07; 100(6):1221-6. PubMed ID: 17206508
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.
    Ravis WR, Llanos-Cuentas A, Sosa N, Kreishman-Deitrick M, Kopydlowski KM, Nielsen C, Smith KS, Smith PL, Ransom JH, Lin YJ, Grogl M.
    Antimicrob Agents Chemother; 2013 Oct 07; 57(10):4809-15. PubMed ID: 23877689
    [Abstract] [Full Text] [Related]

  • 30. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.
    Iqbal J, Bukhari I, Jamshid M, Bashir S, Masoom Yasinzai M, Anwar M.
    East Mediterr Health J; 2006 Sep 07; 12(5):685-9. PubMed ID: 17333810
    [Abstract] [Full Text] [Related]

  • 31. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N, Pascale JM, Jiménez AI, Norwood JA, Kreishman-Detrick M, Weina PJ, Lawrence K, McCarthy WF, Adams RC, Scott C, Ransom J, Tang D, Grogl M.
    PLoS Negl Trop Dis; 2019 May 07; 13(5):e0007253. PubMed ID: 31048871
    [Abstract] [Full Text] [Related]

  • 32. The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model.
    Livneh A, Youngster I, El-On Y, Berkovitch M, Abu-Kishk I.
    Acta Parasitol; 2015 Jun 07; 60(2):345-9. PubMed ID: 26204005
    [Abstract] [Full Text] [Related]

  • 33. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L, Cawich F, Craig P, Sosa JX, el-On J.
    J Am Acad Dermatol; 1993 Sep 07; 29(3):443-6. PubMed ID: 8349861
    [Abstract] [Full Text] [Related]

  • 34. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A, Stipić T, Skerlev M, Basta-Juzbasić A.
    J Eur Acad Dermatol Venereol; 1999 Nov 07; 13(3):214-7. PubMed ID: 10642059
    [Abstract] [Full Text] [Related]

  • 35. Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
    Fernandes AP, Carvalho FA, Tavares CA, Santiago HC, Castro GA, Tafuri WL, Ferreira LA, Gazzinelli RT.
    J Infect Dis; 2001 Jun 01; 183(11):1646-52. PubMed ID: 11343214
    [Abstract] [Full Text] [Related]

  • 36. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J, Moreno E, Calvo A, Blanco L, Fernández-Rubio C, Sanmartín C, Nguewa P, Irache JM, Larrea E, Espuelas S.
    J Dermatol Sci; 2018 Oct 01; 92(1):78-88. PubMed ID: 30037731
    [Abstract] [Full Text] [Related]

  • 37. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.
    el-Safi SH, Murphy AG, Bryceson AD, Neal RA.
    Trans R Soc Trop Med Hyg; 1990 Oct 01; 84(5):690-1. PubMed ID: 2278070
    [No Abstract] [Full Text] [Related]

  • 38. Cutaneous Leishmaniasis in an American Adolescent Returning From Israel.
    Ganjaei KG, Lawton K, Gaur S.
    J Pediatric Infect Dis Soc; 2018 Aug 17; 7(3):e178-e181. PubMed ID: 29878238
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
    Sahibzada NJ, Tareen AK, Khursheed T, Darr N.
    J Pak Med Assoc; 1996 Mar 17; 46(3):53-5. PubMed ID: 8991348
    [Abstract] [Full Text] [Related]

  • 40. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama.
    Sosa N, Capitán Z, Nieto J, Nieto M, Calzada J, Paz H, Spadafora C, Kreishman-Deitrick M, Kopydlowski K, Ullman D, McCarthy WF, Ransom J, Berman J, Scott C, Grogl M.
    Am J Trop Med Hyg; 2013 Sep 17; 89(3):557-563. PubMed ID: 23857024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.